作为对维生素K1的酶选择性受体的动态环二紧固件
Zhuoer Wang1, Yitong Gai1, Aiyou Hao1
1School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China.
Nano letters
|July 4, 2025
概括
研究人员设计了新的折叠式环,在溶剂的作用下改变形状,并且可以识别维生素K1 (VK1). 这些可适应的分子为奇拉感应和人工受体提供了新的可能性.
科学领域:
- 超分子化学 超分子化学
- 有机化学 有机化学
- 生物分子识别 生物分子识别
背景情况:
- 循环二是一种循环,具有多样化的应用.
- 设计具有动态构造变化的分子对于先进材料至关重要.
- 维生素K1 (VK1) 是一种必不可少的生物分子,具有特定的识别要求.
研究的目的:
- 开发具有适应性构成过渡的新型折叠环.
- 研究这些环二对各种溶剂的反应.
- 探索使用这些设计分子对维生素K1 (VK1) 的酶选择性识别.
主要方法:
- 用多环芳化合物 (烯,烯,氨酸) 改造基于氨酸的循环二.
- 溶剂诱导的结构分析,重点是二甲基硫氧化物 (DMSO).
- 石眼性能测量和循环极化发光 (CPL) 研究.
- 绑定亲和度测试和自我组装的纳米架构表征用于VK1识别.
主要成果:
- 合成的性折叠环,对DMSO表现出超高的敏感性,诱导着形状转变和逆转螺丝感.
- 根据溶剂诱导的形状变化,证明了可调整的手术光学特性.
- 折叠的循环二作为分子,通过电荷转移复合在DMSO/水混合物中识别VK1.
- 通过d,d-和l,l-配置的循环二来实现VK1的酶选择性识别,通过差异结合和CPL反应证明了这一点.
结论:
- 开发了可适应的折叠式环,具有溶剂响应的形状动态.
- 通过溶剂诱导的二分化建立了一种可调整的手术光学特性方法.
- 展示了这些环二的潜力,作为生物分子识别的高效分子.
- 为设计基于环酸的先进人工受体和性感应平台提供了基础.
相关概念视频
Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization
2.6K
Dieckmann cyclization is an intramolecular Claisen condensation of diesters. The reaction occurs in the presence of a base and generates a cyclic β-ketoester as the final product. Commonly, 1, 6 and 1, 7-diesters are preferred substrates for the reaction since the generated five, and six-membered cyclic β-keto esters are particularly more stable.
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Pinching-off of Coated Vesicles
3.3K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.3K
Clathrin Coated Vesicles
7.3K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
7.3K
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
4.8K
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
4.8K
Prochirality
4.0K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
4.0K


